Physician profile
David Halstead
NPI 1407843469
$2,249.77
in general payments reported to CMS, 2019-2025
17 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $182 · 2021: $51.80 · 2022: $58.03 · 2023: $188 · 2024: $175 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,431.44 | 2019-2020 | |
| Treace Medical Concepts, INC. | $169.68 | 2022-2025 | |
| Depuy Synthes Sales INC. | $122.52 | 2022-2025 | Na, Hammerlock, N/A |
| Paragon 28, INC. | $102.36 | 2021-2025 | Mtp |
| Zimmer Biomet Holdings, INC. | $86.40 | 2020 | |
| Solventum Corporation | $64.73 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Paratek Pharmaceuticals, INC. | $59.32 | 2021-2025 | Nuzyra |
| Stryker Corporation | $42.59 | 2023-2024 | Easyfuse, Ortholoc 2 Lapifuse |
| Heron Therapeutics, INC. | $37.47 | 2021-2025 | Zynrelef |
| Convatec INC. | $25.16 | 2024 | |
| Integra Lifesciences Corporation | $23.15 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $15.49 | 2025 | Arista |
| Dynasplint Systems INC. | $14.43 | 2025 | Dynasplint |
| Medwest Associates | $14.19 | 2023 | |
| Abbvie INC. | $14.09 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.52 | 2022 | |
| Orthofix Medical, INC. | $13.23 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Halstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.